CCCC
C4 Therapeutics, Inc.
stockNASDAQ
Market OpenOct 13, 2026 9:47:54 AM EDT
3.00USD-1.961%(-0.06)201,130
Loading…
Loading…
367.85M
Healthcare
Biotechnology
HQ
Watertown, MA, USA
146
Previous Close
$3.07
Beta
1.89
52-Week High
$5.17 2026-06-30
52-Week Low
$1.69 2026-02-05
SMA 50
$3.56
SMA 200
$3.14
Avg. Vol 10D
2.21M
Avg. Vol 30D
2.11M
Avg. Vol 90D
2.72M
Relative Vol
0.09
123.03M
83.71M
68.04%
40,395,665
48.26%
17.65
55%/45%
52.58%
31.98%
0.4100%
2,500,000
110
1,796
6,646
Nov 5, 2026 (23d)
Oct 9, 2026
JPMorgan initiates C4 Therapeutics stock coverage at Overweight · 
Investing.com
Oct 2, 2026
Sep 25, 2026
C4 Therapeutics presents cemsidomide trial biomarker data · Investing.com
CCCC Profile
c4 therapeutics is an early stage drug discovery company whose mission is to harness targeted protein degradation to develop therapeutics for a broad range of diseases. the centerpiece of our approach is the degronimid® platform, which enables highly selective small molecule binders to target disease causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system.
CCCC Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.88 | 2026-10-06 | +3.82% | 11.694 |
| 1M | 3.43 | 2026-09-14 | -12.83% | -0.650 |
| 3M | 3.92 | 2026-07-13 | -23.72% | 0.830 |
| 6M | 2.76 | 2026-04-13 | +8.33% | 0.978 |
| 1Y | 2.11 | 2025-10-13 | +41.71% | 1.894 |
| 2Y | 5.88 | 2024-10-14 | -49.15% | — |
| 5Y | 41.58 | 2021-10-13 | -92.81% | 2.005 |
CCCC Stock Summary
C4 Therapeutics, Inc. (NASDAQ:CCCC) stock price today is $2.99, and today's volume is 196,147. CCCC is down 2.288% today. The 30 day average volume is 2.11M. CCCC market cap is $367.85M with 123.03M shares outstanding.